Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization

被引:350
作者
Abdalla, EK
Barnett, CC
Doherty, D
Curley, SA
Vauthey, JN
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
D O I
10.1001/archsurg.137.6.675
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: Preoperative portal vein embolization (PVE) allows potentially curative hepatic resection without additional morbidity or mortality in patients with hepatobiliary malignancies who are marginal candidates for resection based on small liver remnant size. Design: A retrospective review of a consecutive series of patients in a multi-institutional database who underwent extended hepatectomy. Setting: University-based referral centers. Patients: Forty-two patients underwent preoperative determination of the future liver remnant (FLR) volume before extended hepatectomy (greater than or equal to5 segments) for hepatobiliary malignancy without chronic underlying liver disease. Patients were stratified by treatment with or without preoperative PVE. Intervention: Preoperative percutaneous PVE Main Outcome Measures: Clinical characteristics, FLR volume, operative morbidity, and survival. Results: There was no difference between the groups that did and did not undergo PVE for the number of tumors, tumor size, estimated blood loss, duration of the operation, complexity of resection, or surgical margins. The FLR at presentation was significantly smaller in patients who underwent PVE than in patients who did not undergo PVE (18% vs 23%; P<.001). After PVE, FLR volumes increased significantly (P=.003); preoperative FLR volumes were similar in both groups (patients who underwent PVE, 25%; and patients who did not undergo PVE, 23%). There was no perioperative mortality and no statistical difference in the incidence of perioperative complications between those who did and those who did not undergo PVE (5 [28%] of 18 patients vs 5 [21%] of 24 patients). The overall 3-year survival was 65% and the median survival duration was equivalent in the 2 groups (40 vs 52 months for those who did vs those who did not undergo PVE). Conclusion: Portal vein embolization enables safe and potentially curative extended hepatectomy in a subset of patients who would otherwise be marginal candidates for resection based on a small liver remnant size.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 36 条
  • [1] Portal vein embolization: rationale, technique and future prospects
    Abdalla, EK
    Hicks, ME
    Vauthey, JN
    [J]. BRITISH JOURNAL OF SURGERY, 2001, 88 (02) : 165 - 175
  • [2] [Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
  • [3] Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
    Azoulay, D
    Castaing, D
    Smail, A
    Adam, R
    Cailliez, V
    Laurent, A
    Lemoine, A
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2000, 231 (04) : 480 - 486
  • [4] Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    Belghiti, J
    Hiramatsu, K
    Benoist, S
    Massault, PP
    Sauvanet, A
    Farges, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 38 - 46
  • [5] Underlying liver disease, not tumor factors, predicts long-term survival alter resection of hepatocellular carcinoma
    Bilimoria, MM
    Lauwers, GY
    Doherty, DA
    Nagorncy, DM
    Belghiti, J
    Do, KA
    Regimbeau, JM
    Ellis, LM
    Curley, SA
    Ikai, I
    Yamaoka, Y
    Vauthey, JN
    [J]. ARCHIVES OF SURGERY, 2001, 136 (05) : 528 - 534
  • [6] Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
  • [7] CUNNINGHAM JD, 1994, ARCH SURG-CHICAGO, V129, P1050
  • [8] *CYT SOFTW CORP, 1997, STATX WIND US MAN
  • [9] *DAT AN PROD DIV, 1998, S PLUS 5 UN GUID STA
  • [10] Elias D, 1999, ANN CHIR, V53, P559